CN Stock MarketDetailed Quotes

301257 SMO Clinplus

Watchlist
  • 46.82
  • +1.71+3.79%
Market Closed May 6 15:00 CST
2.86BMarket Cap21.67P/E (TTM)

About SMO Clinplus Company

The company is committed to undertaking SMO projects with innovative and high clinical value new drugs, helping sponsors to efficiently and quickly advance the implementation and execution of clinical trials, and to enable new drug research and development. As a big data-driven clinical trial service provider, the company provides domestic and foreign pharmaceutical companies and other customers with services including early preparation plans, trial site start-up, on-site execution, and full project process management. Corporate honors: 2021 Shanghai “Specialized, Special and New” Enterprise, Huangpu District Enterprise Technology Center, Shanghai Science and Technology Little Giant Enterprise, High-tech Enterprise, etc.

Company Profile

Short Name-A普蕊斯
Symbol-A301257
Company NameSMO Clinplus Co., Ltd.
Listing DateMay 17, 2022
Issue Price46.80
Shares Offered15.00M share(s)
FoundedFeb 22, 2013
Legal Representativechunbao lai
CEOhongwei yang
Secretaryxiaolong lai
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativejing ren
Legal CounselBeijing Guo Feng (Shanghai) Law Firm
Employees3978
Phone021-60755800
Office Address23rd Floor, World Trade Tower, 500 Guangdong Road, Huangpu District, Shanghai
Zip Code200001
Registered AddressRoom 108, Building 1, No. 105 Sinan Road, Huangpu District, Shanghai
Fax021-60755803
EmailIR@smo-clinplus.com
Business License310115002079365
BusinessEngage in technology development, technology transfer, technical consulting, and technical services in the pharmaceutical field, and engage in the import and export business of goods and technology. [For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments].

Company Executives

  • Name
  • Position
  • Salary
  • chunbao lai
  • Chairman,directors
  • 513.00K
  • hongwei yang
  • directors,general manager
  • 1.64M
  • xiaorong fan
  • directors
  • --
  • xiaolong lai
  • directors,Board Secretary
  • 724.90K
  • ranting qian
  • directors
  • --
  • lin ma
  • directors
  • --
  • xue liu
  • Independent directors
  • 100.00K
  • xiansheng liao
  • Independent directors
  • 93.30K
  • huasheng huang
  • Independent directors
  • 93.30K
  • jing ren
  • Securities affairs representative
  • --
  • yuping ma
  • Chairman of the Supervisory Board,auditors
  • --
  • deyong tan
  • auditors
  • --
  • ting chang
  • Deputy General Manager
  • 850.10K
  • yue wang
  • Deputy General Manager
  • 726.90K
  • jing zhao
  • Deputy General Manager
  • 480.10K
  • xia chen
  • Deputy General Manager
  • 807.40K
  • weihong song
  • Chief Financial Officer
  • 962.30K
  • shengnan gu
  • Employee supervisors
  • 326.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg